In 2005, two landmark studies showed that PARPi selectively killed breast cancer allele 1 or breast cancer allele 2 (BRCA1/BRCA2)-deficient cancer cells by inducing the collapse of replication forks [24, 25]. Here, BRCA2 is linked to cancer.